Long-term Outcomes and Recovery of Patients who Survived COVID-19: LUNG INJURY COVID-19 Study.
Gianna Vargas CentanaroMyriam CalleJosé Luis Álvarez-Sala WaltherFernando Martinez-SagastiAndrea Albuja HidalgoRafael Herranz HernándezJuan Luis Rodríguez HermosaPublished in: Open forum infectious diseases (2022)
At 12 months from infection onset, most patients refer to symptoms, particularly muscle weakness and dyspnea, and almost one-third of patients with severe COVID-19 pneumonia had impaired pulmonary diffusion and abnormalities on chest radiology imaging. These results emphasize the importance of systematic follow-up after severe COVID-19, with appropriate management of pulmonary sequelae.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- pulmonary hypertension
- ejection fraction
- respiratory syndrome coronavirus
- chronic kidney disease
- newly diagnosed
- high resolution
- early onset
- skeletal muscle
- prognostic factors
- peritoneal dialysis
- machine learning
- palliative care
- photodynamic therapy
- deep learning
- fluorescence imaging
- patient reported outcomes
- community acquired pneumonia